(Q39602547)

13 September 2017

title

Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens (English)

1 reference

13 September 2017

Yoshimasa Tanaka

2

0 references

Masakazu Toi

7

object named as

Masakazu Toi

1 reference

13 September 2017

Masashi Iwasaki

1

1 reference

13 September 2017

Hirohito Kobayashi

3

1 reference

13 September 2017

Kaoru Murata-Hirai

4

1 reference

13 September 2017

Hideto Miyabe

5

1 reference

13 September 2017

Tomoharu Sugie

6

1 reference

13 September 2017

Nagahiro Minato

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

11 January 2011

1 reference

European Journal of Immunology

13 September 2017

published in

1 reference

13 September 2017

volume

41

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

345-355

1 reference

Nonpeptide ligands for human gamma delta T cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Gamma delta T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Studies on the nonmevalonate terpene biosynthetic pathway: metabolic role of IspH (LytB) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Gammadelta T cells and the lymphoid stress-surveillance response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Effector functions and control of human gammadelta T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

PD-1 and PD-1 ligands: from discovery to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

B7-H1 pathway and its role in the evasion of tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Perspectives of gammadelta T cells in tumor immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Potential of human gammadelta T lymphocytes for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

inferred from DOI database lookup

7 January 2021

based on heuristic

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

inferred from DOI database lookup

7 January 2021

based on heuristic

Gamma/delta T-cell stimulation by pamidronate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040959

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.201040959

1 reference

13 September 2017

1 reference